SLC5A2 and endocrine system disorder: Pharmacokinetic/pharmacodynamic studies of drugs commonly used to treat metabolic and endocrine diseases (metformin, levothyroxine, SGLT-2 inhibitors, etc.)are necessary to improve outcomes.